Cargando…
Safety, efficacy and biomarkers analysis of mesenchymal stromal cells therapy in ARDS: a systematic review and meta-analysis based on phase I and II RCTs
BACKGROUND: Mesenchymal stromal cells (MSCs) therapy for acute respiratory distress syndrome (ARDS) is an emerging treatment, but most of the current trials of MSCs stay in the animal experimental stage, and the safety and efficacy of MSCs in clinical application are not clear. We aimed to analyze t...
Autores principales: | Wang, Jianbao, Luo, Fenbin, Suo, Ye, Zheng, Yuxin, Chen, Kaikai, You, Deyuan, Liu, Yuqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233855/ https://www.ncbi.nlm.nih.gov/pubmed/35752865 http://dx.doi.org/10.1186/s13287-022-02956-3 |
Ejemplares similares
-
The safety and efficacy of mesenchymal stromal cells in ARDS: a meta-analysis of randomized controlled trials
por: Wang, Fengyun, et al.
Publicado: (2023) -
Linezolid in the treatment of severe intraabdominal infection: A STROBE-compliant retrospective study
por: You, Deyuan, et al.
Publicado: (2022) -
Inclusion and Analysis of Older Adults in RCTs
por: Van de Water, W., et al.
Publicado: (2011) -
Mesenchymal stromal cells reduce evidence of lung injury in patients with ARDS
por: Wick, Katherine D., et al.
Publicado: (2021) -
Meta-Analysis Based on Clinical RCTs: The Effect of Molecular Epimerism on the Safety of Glycyrrhizic Acid
por: Chen, Hongdou, et al.
Publicado: (2020)